References
Albagha O M, Visconti M R, Alonso N, Langston A L, Cundy T, Dargie R, Dunlop M G, Fraser W D, et al. 2010 Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone; Nat. Genet. 42 520–524
Anborgh P H, Godin C, Pampillo M, Dhami G K, Dale L B, Cregan S P, Truant R and Ferguson S S 2005 Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin; J. Biol. Chem. 280 34840–34848
Chalasani M L, Radha V, Gupta V, Agarwal N, Balasubramanian D and Swarup G 2007 A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants; Invest Ophthalmol. Vis. Sci. 48 1607–1614
Chalasani M L, Swarup G and Balasubramanian D 2009 Optineurin and its mutants: molecules associated with some forms of glaucoma; Ophthalmic Res. 42 176–184
Chi Z L, Akahori M, Obazawa M, Minami M, Noda T, Nakaya N, Tomarev S, Kawase K, et al. 2010 Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice; Hum. Mol. Genet. 19 2606–2615
Chibalina M V, Poliakov A, Kendrick-Jones J and Buss F 2010 Myosin VI and optineurin are required for polarised EGFR delivery and directed migration; Traffic (Epublication ahead of print)
del Toro D, Alberch J, Lazaro-Dieguez F, Martin-Ibanez R, Xifro X, Egea G and Canals J M 2009 Mutant Huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus; Mol. Biol. Cell 20 1478–1492
Hattula K and Peränen J 2000 FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis; Curr. Biol. 10 1603–1606
Hayden M.S and Ghosh S 2008 Shared principles in NF-κB signalling; Cell 132 344–362
Journo C, Filipe J, About F, Chevalier S A, Afonso P V, Brady J N, Flynn D, Tangy F, et al. 2009 NRP/Optineurin Cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein; PLoS Pathog. 5 e1000521
Mankouri J, Fragkoudis R, Richards K H, Wetherill L F, Harris M, Kohl A, Elliott R M and Macdonald A. 2010 Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection; PLoS Pathog. 6 e1000778
Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M et al. 2010 Mutations of optineurin in amyotrophic lateral sclerosis; Nature (London) 465 223–226
Mattson M P and Meffert M K 2006 Roles for NF-κB in nerve cell survival, plasticity, and disease; Cell Death Differ. 13 852–860
Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E, Liebmann J, Ritch R, Héon E et al. 2005 Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1; Hum. Mol. Genet. 14 725–733
Morton S, Hesson L, Peggie M and Cohen P 2008 Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma; FEBS Lett. 582 997–1002
Nagabhushana A, Chalasani M L, Jain N, Radha V, Rangaraj N, Balasubramanian D and Swarup G 2010 Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant; BMC Cell Biol. 11 4
Park B, Ying H, Shen X, Park J S, Qiu Y, Shyam R and Yue BY 2010 Impairment of protein trafficking upon overexpression and mutation of optineurin; PLoS One 5 e11547
Park B C, Shen X, Samaraweera M and Yue BY 2006 Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types; Am. J. Pathol. 169 1976–1989
Pease M E, McKinnon S J, Quigley H A, Kerrigan-Baumrind L A and Zack D J 2000 Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma; Invest Ophthalmol. Vis. Sci. 41 764–774
Quigley H A 1999 Neuronal death in glaucoma; Prog. Retin. Eye Res. 18 39–57
Ray K and Mookherjee S 2009 Molecular complexity of primary open angle glaucoma: current concept; J. Genet. 88 451–467
Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Heon E, Krupin T, et al. 2002 Adult-onset primary open-angle glaucoma caused by mutations in optineurin; Science 295 1077–1079
Sahlender D A, Roberts R C, Arden S D, Spudich G, Taylor M J, Luzio J P, Kendrick-Jones J and Buss F 2005 Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis; J. Cell Biol. 169 285–295
Sudhakar C, Nagabhushana A, Jain N and Swarup G 2009 NF-κB Mediates Tumor Necrosis Factor α-Induced Expression of Optineurin, a Negative Regulator of NF-κB; PLoS One 4 e5114
Stone E M, Fingert J H, Alward W L, Nguyen T D, Polansky J R, Sunden S L F, Nishimura D, Clark A F et al. 1997 Identification of a gene that causes primary open angle glaucoma; Science 275 668–670
Weisschuh N, Alavi M V, Bonin M and Wissinger B 2007 Identification of genes that are linked with optineurin expression using a combined RNAi—microarray approach; Exp. Eye Res. 85 450–461
Ying H, Shen X, Park B and Yue BY 2010 Posttranslational modifications, localization, and protein interactions of optineurin, the product of a glaucoma gene; PLoS One. 5 e9168
Zhu G, Wu C J, Zhao Y and Ashwell J D 2007 Optineurin negatively regulates TNFα-inducedNF-κB activation by competing with NEMO for ubiquitinated RIP; Curr. Biol. 17 1438–1443
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Swarup, G., Nagabhushana, A. Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling. J Biosci 35, 501–505 (2010). https://doi.org/10.1007/s12038-010-0056-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-010-0056-9